Comparative Motor Pre-clinical Assessment in Parkinson’s Disease Using Supervised Machine Learning Approaches
- 264 Downloads
Millions of people worldwide are affected by Parkinson’s disease (PD), which significantly worsens their quality of life. Currently, the diagnosis is based on assessment of motor symptoms, but interest toward non-motor symptoms is increasing, as well. Among them, idiopathic hyposmia (IH) is associated with an increased risk of developing PD in healthy adults. In this work, a wearable inertial device, named SensFoot V2, was used to acquire motor data from 30 healthy subjects, 30 people with IH, and 30 PD patients while performing tasks from the MDS-UPDRS III for lower limb assessment. The most significant and non-correlated extracted parameters were selected in a feature array that can identify differences between the three groups of people. A comparative classification analysis was performed by applying three supervised machine learning algorithms. The system resulted able to distinguish between healthy and patients (specificity and recall equal to 0.967), and the people with IH can be identified as a separate class within a three-group classification (accuracy equal to 0.78). Thus, the system could support the clinician in objective assessment of PD. Further, identification of IH together with changes in motor parameters could be a non-invasive two-step approach to investigate the early onset of PD.
KeywordsDecision support systems Idiopathic hyposmia Inertial wearable sensors Motion analysis Supervised learning
This work was financially supported by DAPHNE project (Regione Toscana PAR FAS 2007-2013, Bando FAS SALUTE 2014, CUP J52I16000170002).
- 1.Al-Aidaroos, K. M., A. Abu Bakar, and Z. Othman. Naïve Bayes variants in classification learning. Proc.—2010 Int. Conf. Inf. Retr. Knowl. Manag. Explor. Invis. World, CAMP’10 276–281, 2010. https://doi.org/10.1109/infrkm.2010.5466902.
- 2.Alam, M. N., A. Garg, T. T. K. Munia, R. Fazel-Rezai, and K. Tavakolian. Vertical ground reaction force marker for Parkinson’s disease. PLoS ONE 12:1–13, 2017.Google Scholar
- 3.Antonini, A., R. Benti, S. De Notaris, S. Tesei, A. Zecchinelli, G. Sacilotto, N. Meucci, M. Canesi, C. Mariani, G. Pezzoli, et al. 123I-Ioflupane/SPECT binding to striatal dopamine transporter (DAT) uptake in patients with Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy. Neurol. Sci. 24:149–150, 2003.CrossRefGoogle Scholar
- 7.Berg, D., A. E. Lang, R. B. Postuma, W. Maetzler, G. Deuschl, T. Gasser, A. Siderowf, A. H. Schapira, W. Oertel, J. A. Obeso, C. W. Olanow, W. Poewe, and M. Stern. Changing the research criteria for the diagnosis of Parkinson’s disease: obstacles and opportunities. Lancet Neurol. 12:514–524, 2013.CrossRefGoogle Scholar
- 10.Dorsey, E. R., R. Constantinescu, J. P. Thompson, K. M. Biglan, R. G. Holloway, K. Kieburtz, F. J. Marshall, B. M. Ravina, G. Schifitto, A. Siderowf, and C. M. Tanner. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 68(5):384–386, 2007.CrossRefGoogle Scholar
- 11.Fahn, S. Clinical aspects of Parkinson disease. In: Parkinson’s disease: molecular and therapeutic insights from model systems, edited by R. Nass, and S. Przedborski. Amsterdam: Elsevier Inc., 2008, pp. 3–48.Google Scholar
- 15.Goetz, C. G., B. C. Tilley, S. R. Shaftman, G. T. Stebbins, S. Fahn, P. Martinez-Martin, W. Poewe, C. Sampaio, M. Stern, R. Dodel, B. Dubois, R. G. Holloway, J. Jankovic, J. Kulisevsky, A. E. Lang, A. J. Lees, S. Leurgans, P. A. LeWitt, D. Nyenhuis, C. W. Olanow, O. Rascol, A. Schrag, J. A. Teresi, J. J. van Hilten, and N. LaPelle. Movement disorder society-sponsored revision of the unified Parkinson’s disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov. Disord. 23:2129–2170, 2008.CrossRefGoogle Scholar
- 19.Kim, J., B. S. Kim, and S. Savarese. Comparing image classification methods: K-nearest-neighbor and support-vector-machines. Stevens Point: World Scientific and Engineering Academy and Society (WSEAS), pp. 133–138, 2012.Google Scholar
- 22.Maremmani, C., F. Cavallo, C. Purcaro, G. Rossi, S. Salvadori, E. Rovini, D. Esposito, A. Pieroni, S. Ramat, P. Vanni, B. Fattori, and G. Meco. Combining olfactory test and motion analysis sensors in Parkinson’s disease preclinical diagnosis: a pilot study. Acta Neurol. Scand. 137:204–211, 2018.CrossRefGoogle Scholar
- 23.Maremmani, C., G. Rossi, N. Tambasco, B. Fattori, A. Pieroni, S. Ramat, A. Napolitano, P. Vanni, P. Serra, P. Piersanti, M. Zanetti, M. Coltelli, M. Orsini, R. Marconi, C. Purcaro, A. Rossi, P. Calabresi, and G. Meco. The validity and reliability of the Italian olfactory identification test (IOIT) in healthy subjects and in Parkinson’s disease patients. Parkinsonism Relat. Disord. 18:788–793, 2012.CrossRefGoogle Scholar
- 35.Yan, K. YAN-PRTools., 2016. https://it.mathworks.com/matlabcentral/fileexchange/56723-yan-prtools.